These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31757757)

  • 21. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells.
    Kelley CP; Haerle MC; Wang ET
    Cell Rep; 2022 Aug; 40(7):111226. PubMed ID: 35977479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-dCas9 and sgRNA scaffolds enable dual-colour live imaging of satellite sequences and repeat-enriched individual loci.
    Fu Y; Rocha PP; Luo VM; Raviram R; Deng Y; Mazzoni EO; Skok JA
    Nat Commun; 2016 May; 7():11707. PubMed ID: 27222091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico optimization of RNA-protein interactions for CRISPR-Cas13-based antimicrobials.
    Park HM; Park Y; Berani U; Bang E; Vankerschaver J; Van Messem A; De Neve W; Shim H
    Biol Direct; 2022 Oct; 17(1):27. PubMed ID: 36207756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA editing with CRISPR-Cas13.
    Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
    Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple and versatile imaging of genomic loci in live mammalian cells and early pre-implantation embryos using CAS-LiveFISH.
    Geng Y; Pertsinidis A
    Sci Rep; 2021 Jun; 11(1):12220. PubMed ID: 34108610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live-Cell Imaging of Genomic Loci Using CRISPR/Molecular Beacon Hybrid Systems.
    Wu X; Ying Y; Mao S; Krueger CJ; Chen AK
    Methods Mol Biol; 2020; 2166():357-372. PubMed ID: 32710420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targeting.
    Wei J; Lotfy P; Faizi K; Baungaard S; Gibson E; Wang E; Slabodkin H; Kinnaman E; Chandrasekaran S; Kitano H; Durrant MG; Duffy CV; Pawluk A; Hsu PD; Konermann S
    Cell Syst; 2023 Dec; 14(12):1087-1102.e13. PubMed ID: 38091991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
    Perčulija V; Lin J; Zhang B; Ouyang S
    Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells.
    Ai Y; Liang D; Wilusz JE
    Nucleic Acids Res; 2022 Jun; 50(11):e65. PubMed ID: 35244715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
    Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
    BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System.
    Nguyen H; Wilson H; Jayakumar S; Kulkarni V; Kulkarni S
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted manipulation of m
    Sun X; Wang DO; Wang J
    Methods; 2022 Jul; 203():56-61. PubMed ID: 35306148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small-Molecule-Mediated Split-Aptamer Assembly for Inducible CRISPR-dCas9 Transcription Activation.
    Liu XH; Li BR; Ying ZM; Tang LJ; Wang F; Jiang JH
    ACS Chem Biol; 2022 Jul; 17(7):1769-1777. PubMed ID: 35700146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Customized optical mapping by CRISPR-Cas9 mediated DNA labeling with multiple sgRNAs.
    Abid HZ; Young E; McCaffrey J; Raseley K; Varapula D; Wang HY; Piazza D; Mell J; Xiao M
    Nucleic Acids Res; 2021 Jan; 49(2):e8. PubMed ID: 33231685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Domains of NEAT1 Architectural lncRNA Induce Paraspeckle Assembly through Phase Separation.
    Yamazaki T; Souquere S; Chujo T; Kobelke S; Chong YS; Fox AH; Bond CS; Nakagawa S; Pierron G; Hirose T
    Mol Cell; 2018 Jun; 70(6):1038-1053.e7. PubMed ID: 29932899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.